COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-Saharan Africa.

Bisi BrightChinedum Peace BabalolaNadia Adjoa Sam-AguduAugustine Anayochukwu OnyeaghalaAdebola OlatunjiUfuoma AduhPatrick O SobandeTrevor A CrowellYenew Kebede TebejeSunny PhillipNicaise NdembiMorenike Oluwatoyin Folayan

Published in: Globalization and health (2021)

Access to vaccines, therapeutics, and diagnostics for COVID-19 will be a challenge for sub-Saharan Africans. This challenge should be confronted by collaborating with vaccine developers; pooled procurement of COVID-19 therapeutics; and local development of testing and diagnostic materials. The COVID-19 pandemic should be a wake-up call for sub-Saharan Africa to build vaccines, therapeutics, and diagnostics manufacturing capacity as one of the resources needed to address public-health crises.

Keyphrases

coronavirus disease
public health
sars cov
small molecule
respiratory syndrome coronavirus
clinical trial
open label
infectious diseases